Us Bancorp \De\ Milestone Pharmaceuticals Inc. Transaction History
Us Bancorp \De\
- $74.1 Billion
- Q1 2025
A detailed history of Us Bancorp \De\ transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 3,200 shares of MIST stock, worth $4,256. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,200Holding current value
$4,256% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MIST
# of Institutions
52Shares Held
25.2MCall Options Held
61.2KPut Options Held
38.8K-
Black Rock Inc. New York, NY4.97MShares$6.61 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.7MShares$3.6 Million0.0% of portfolio
-
Alta Fundamental Advisers LLC New York, NY2.66MShares$3.54 Million2.16% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$3.33 Million0.1% of portfolio
-
Orbimed Advisors LLC San Diego, CA2MShares$2.66 Million0.13% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $39.9M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...